Read the latest reports on Western Europe, with local insight, sp...
Read the latest reports on Western Europe, with local insight, specialist knowledge and a comprehensive breakdown of key market data. Our research identifies key strategic themes relevant across the region, while also providing a more granular unders...
In 2023, rising prices led to a dramatic increase in current value sales of retail tissue, as manufacturers passed on higher costs to consumers. Retail volume sales increased marginally in the year, as consumption patterns normalised given the full…
Retail tissue in Switzerland reported growth across all subcategories in 2023, with toilet paper the largest product category overall. Spending patterns are normalising after the pandemic resulting in steady demand for retail tissue products such as…
In 2023, retail value sales of retail tissue in the Netherlands experienced solid growth. However, declining disposable incomes are leading some consumers to decrease their usage of toilet paper. Adjustments in their purchasing behaviour have…
Inflationary pressures in 2023 marginally eased when compared to the previous year, but continued to exert strong influence on demand for retail tissue in the UK. Sales mostly rebounded in the second half of 2023, although not sufficiently to avoid…
Retail tissue demonstrated a single-digit volume growth in 2023, spurred partly by population growth and increased demand. Bulk purchases ahead of significant price increases in July 2023 also contributed to this modest growth, along with promotional…
Rx/reimbursement adult incontinence recorded strong growth in current value terms in 2023 continuing the trend of the previous year. However, this was mainly due to prevailing inflationary pressures, as rising raw material, production and transport…
The year 2023 witnessed a notable increase in demand for RX/reimbursement adult incontinence products in Belgium, spurred by several key drivers. Firstly, Belgium's ageing population continued to fuel sustained demand for such products. Additionally,…
Noteworthy unit price increases in 2023 also affected Rx/Reimbursement adult incontinence in Denmark. Significant price increases were driven by cost inflation covering aspects like energy, material sourcing, labour, logistics and supply chain…
Rx/reimbursement adult incontinence in France continued its positive growth trend in 2023, in terms of both volume and current value sales, benefitting from the essential nature of the category’s products. There was a small deceleration in the first…
In 2023, rx/reimbursement adult incontinence in Germany continued to record positive value growth, particularly given the increased costs of products and the impact of a high inflation rate. Nevertheless, volume growth decreased marginally, in a…